BDBM463299 4-amino-5-(5-chloro- 4-hydroxypyridin-2- yl)-2-{8-(2-fluorobenzyl)- [1,2,4]triazolo[1,5-a]- pyrazin-6-yl}-5-methyl- 5,7-dihydro-6H-pyrrolo- [2,3-c]pyrimidin-6-one::US10780092, Example 148-B

SMILES CC1(C(=O)Nc2nc(nc(N)c12)-c1cn2ncnc2c(Cc2ccccc2F)n1)c1cc(O)c(Cl)cn1

InChI Key InChIKey=SZWFXUFEKQDKFH-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 463299   

TargetGuanylate cyclase soluble subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM463299(4-amino-5-(5-chloro- 4-hydroxypyridin-2- yl)-2-{8-...)
Affinity DataKi:  0.261nMAssay Description:The binding potencies of sGC compounds to the human recombinant sGC enzyme were determined in a Size Exclusion Chromatography (SEC) competition bindi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2021
Entry Details
US Patent